Background: Genetic variations have been proposed to play a role in the susceptibility to diabetic nephropathy. Objectives: To check for the association of genetic polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and angiotensin converting enzyme (ACE) genes with the development of diabetic nephropathy among type 2 diabetic patients. Methods: Participants comprised 202 patients with type 2 diabetes, of whom 102 were affected with diabetic nephropathy. Genetic variants corresponding to MTHFR C677T, A1298C and ACE I/D genotypes were determined using the PCR technique coupled with digestion and restriction analysis. Results: Cases with diabetic nephropathy had a significantly higher frequency of the MTHFR 677 TT, 677 CT, ACE DD mutant genotypes compared with diabetic cases without nephropathy. Analysis of the association of studied MTHFR C677T, A1298C and ACE I/D polymorphisms with albuminuria showed that the MTHFR 677 T polymorphism, in the recessive and dominant models, was a risk factor for both micro and macroalbuminuria, while the ACE DD mutant genotype was a risk factor for microalbuminuria and the MTHFR 1298C in the dominant model only was a risk factor for macroalbuminuria. Conclusion: These findings indicate that ACE and MTHFR genetic polymorphisms might be considered as genetic risk factors for diabetic nephropathy among patients with type 2 diabetes.
Introduction
A genetic predisposition, based on familial clustering of diabetic nephropathy (DN), has been implicated in the pathogenesis of nephropathy in type 2 diabetes mellitus (T2DM). 1 Genetic polymorphisms as described with angiotensin-converting enzyme (ACE) and methylenetetrahydrofolate reductase (MTHFR) genes were studied as giving predisposition to the development of vascular complications of diabetes, albeit with conflicting results. [2] [3] [4] [5] [6] It is known that ACE and angiotensinogen play an important role in blood pressure and blood volume homeostasis. 7 Concentrations of plasma and tissue ACE are determined by the ACE gene located on chromosome 17q23. This gene manifests a 287-bp repeated Alu sequence insertion (I) or deletion (D) polymorphism in intron 16. 8 The homozygous DD genotype, which is associated with a two-to threefold increase in levels of ACE, may cause a variety of adverse cardiovascular effects. 9 Taking into account that inhibitors of ACE are known to be more efficient than other antihypertensives in arresting the development of DN, 10 a number of studies have, in particular, proposed the ACE gene polymorphism as an important genetic factor for DN. 11, 12 MTHFR is a key regulatory enzyme in folate and homocysteine metabolism. Deficiency of MTHFR may be associated with an increase in plasma homocysteine, which in turn is associated with an increased risk of vascular diseases including the predisposition to nephropathy among MTHFR C677T, A1298C and ACE I/D polymorphisms as risk factors for diabetic nephropathy among type 2 diabetic patients diabetic patients. [13] [14] [15] These mutant polymorphisms include two variants, C677T and A1298C, that were shown to affect the enzymatic activity of MTHFR. 16, 17 The aim of this study was to check for the association of polymorphisms related to ACE I/D and MTHFR C677T and A1298C genes with the susceptibility to DN in Egyptian cases with T2DM.
Subjects and method
This study has included cases with T2DM being treated and followed up in the Diabetes and Endocrinology Departments, Internal Medicine Specialized Hospital and Nephrology Center, Mansoura University, Egypt. Inclusion criteria have included cases with: Egyptian origin, age at onset of diabetes >35 years, diabetes duration of ≥10 years, C-peptide ≥0.3 nmol/L with glutamic acid decarboxylase (GAD) antibody negativity. Diabetes diagnosis was based upon WHO criteria with fasting plasma glucose ≥7.0 mmol/L. 18 On the other hand, cases with primary renal disorders were excluded from the study. In total, 202 type 2 diabetic patients were included in the study. These cases were divided into two groups depending on the presence or absence of nephropathy in the form of microalbuminuria (urinary albumin excretion rate of 30 to 299 mg/day or an albumin: creatinine ratio of 2.5 to 25 mg/mmol in males and 3.5 to 25 mg/mmol in females) or macroalbuminuria (levels higher than those already mentioned). 19 The first group consisted of 102 subjects affected with T2DM associated with DN. Their mean age ± standard deviation (SD) was 58.7 ± 6.43 years. They were in the form of 54 (52.9%) males and 48 (47.1%) females. Of them, 32 (31.4%) were affected with microalbuminuria, while the other 70 (68.6%) had macroalbuminuria. The other group was affected with T2DM without nephropathy (n=100), their mean age ± SD was 52.19 ± 8.32 years while their gender was in the form of 30 (30.0%) males and 70 (70.0%) females. An ethical approval was obtained from the scientific and ethical committees of Mansoura University, Egypt. An informed consent was also obtained from all participants before the start of the study.
DNA extraction, amplification and digestion
DNA was extracted using a DNA extraction and purification kit (Gentra Systems, USA) according to the manufacturer's instructions and then stored at -20°C until use. ACE gene I/D polymorphism was determined using PCR amplification of the respective fragments from intron 16 of the ACE gene according to the method described previously. 20 Optimized primer pair was used to amplify the D and I alleles, resulting in 319-bp and 597-bp amplicons, respectively (5′-GCC CTG CAG GTG TCT GCA GCA TGT-3′ and 5′-GGA TGG CTC TCC CCG CCT TGT CTC-3′). The thermocycling profile consisted of denaturation at 94ºC for 30 seconds, annealing at 56ºC for 45 seconds and synthesis at 72ºC for two minutes, repeated for 35 cycles, followed by a final synthesis at 72ºC for seven minutes. Because the D allele in heterozygous samples is preferentially amplified, each sample found to have the DD genotype was subjected to a second, independent PCR amplification with a primer pair that recognizes an insertion-specific sequence (5′-TGG GAC CAC AGC GCC CGC CAC TAC-3′ and 5′-TCG CCA GCC CTC CCA TGC CCA TAA-3′), with identical PCR conditions except for an annealing temperature of 67ºC. The reaction yields a 335-bp amplicon only in the presence of an I allele, and no product in samples homozygous for DD.
MTHFR C677T and A1298C genotypes were determined using the PCR-RFLP technique described previously. 21 The primer sequences for C677T genotypes were: Forward: (5′-TGA AGG AGA AGG TGT CTG CGG GA-3′) and Reverse: (5′-AGG ACG GTG CGG TGA GAG TG-3′) (Gibeo BRL). PCR protocol was in the form of a preliminary denaturation at 95°C for 3 min, five cycles: denaturation at 94°C for 1 min, annealing at 64°C for 1 min, synthesis at 72°C for 30 s; next 30 cycles were run as: denaturation at 94°C for 45 s, annealing at 62°C for 45 s, synthesis at 72°C for 25 s and final synthesis at 72°C for 7 min. Digestion was performed by restrictase HinfI (Fermentas) at 37°C for 4 h. For evaluation of the other MTHFR A1298C polymorphism, the following primers were used: Forward: (5′-CTT TGG GGA GGT GAA GGA CTA CTA C-3′) and Reverse: (5′-CAC TTT GTG AGC ATT CCG GTT TG-3′) (Gibeo BRL). The PCR procedure was composed of preliminary denaturation at 95°C for 2 min, 5 cycles: denaturation at 95°C for 1 min, annealing at 55°C for 2 min, synthesis at 72°C for 2 min; next 32 cycles were run: denaturation at 95°C for 75 s, annealing at 55°C for 75 s, synthesis at 72°C for 90 s and final synthesis at 72°C for 6 min. Restrictase MboII was used for digestion at 37°C for 7 h. Each final reaction volume plus 5 µl of bromophenol blue track dye was loaded into 2% agarose gel (Boehringer Mannheim) containing ethidium bromide. Gels were electrophoresed for 30 min at 100 V, photographed under UV light (320 nm) and then scored for the presence or absence of allele specific bands.
Statistical analysis
Data were processed and analyzed using the Statistical Package of Social Science (SPSS) version 17.0. The frequency of studied allelic polymorphisms among cases was compared with that of controls and tested for positive association using chi-square (χ 2 ) test or Fisher exact tests and odds ratio (OR) with a 95% confidence interval (95% CI).
Furthermore, the distribution of alleles in studied groups was tested for fitting to the Hardy-Weinberg equilibrium through testing the difference between observed and expected frequencies of genetic variants using the χ 2 test. A minimum level of significance was considered if p was < 0.05.
Result
Cases of T2DM with nephropathy showed a significantly higher frequency of the mutant genotypes: MTHFR 677 TT (23.5% vs. 3.0%, OR = 9.95, p<0.0001 ), 677 CT (45.1% vs. 19%, OR=3.5, p<0.0001) and ACE DD (39.2% vs. 23%, OR=2.2, p=0.01); with a significantly lower frequency of wild type genotypes: 677 CC (31.4% vs. 78%, OR=0.13, p<0.0001), 1298AA (52% vs. 69%, OR=0.49, p=0.02) and heterozygous ACE ID genotype (56.9% vs. 72%, OR=0.5, p=0.03) ( Table 1) . Testing genetic equilibrium between the observed and expected genotypes using the Hardy-Weinberg equilibrium showed that the MTHFR genetic variants were conforming to the law. On the other hand, the ACE I/D polymorphism showed a non-fitting pattern that might indicate an enrichment of the mutation among these cases, particularly the cases with nephropathy; an assumption that might still need confirmation through a greater sample size (Table 1) . Regarding allele frequencies, cases with DN had significantly higher frequencies of the mutant alleles: 677 T (OR=5.98, p<0.0001) and 1298 C (OR=1.83, p=0.02). This was confirmed by having significantly higher frequencies of the haplotypes: 677T/1298C (OR=9.31, p=0.0002) and 677T/1298A (OR=4.35, p<0.0001) ( Table 2) .
Analysis of genetic risk factors suggestive of being associated with the development of microalbuminuria showed that MTHFR 677 polymorphism was significantly contributing to it both in the dominant mode (TT+TC vs. (Table 3 ).
Discussion
Studies indicated that both environmental and genetic factors would contribute to the development and progression of diabetic nephropathy. 22 This work showed that T2DM cases had a higher risk to develop nephropathy, particularly in the form of microalbuminuria with particular genetic polymorphisms as MTHFR 677 TT, 677 CT, and the ACE DD genotype, while MTHFR 677 TT, 677 CT and 1298 CC were associated with the risk of developing macroalbuminuria. This was confirmed with positive association between nephropathy and the 677 T, 1298 C alleles and 677T/1298C, 677T/1298A haplotypes. The results concerning positive association with the MTHFR 677 T and 1298 C mutations were in accord with other studies done among Turkish, 23 Tunisian, 15 Chinese, 1, [24] [25] [26] Polish, 27 Iranian 28 and Japanese 29 subjects. Regarding the ACE I/D polymorphism, several studies have previously found an association between the ACE D allele and DN, such as those reported in published metaanalyses, 30, 31 in addition to other studies done among Indians, [32] [33] [34] Japanese, 35, 36 French 37 and Bangladesh 38 diabetic subjects. In addition, there is strong evidence that ACE gene polymorphism was correlated to renoprotection against the development of DN, as reported in the studies done among Danish 39, 40 and Italian 41 diabetic cases.
On the contrary, other studies reported no association between MTHFR C677T polymorphism with the development of nephropathy among diabetic patients, such as those done among Japanese, [42] [43] [44] [45] Turkish, 46 Polish, 47, 48 Korean 49 and Jewish 50 subjects. Similarly MTHFR A1298C polymorphism was reported to be negatively associated with DN in the studies done among Jewish 50 and Polish 48 cases. Similarly, lack of an association between kidney function and ACE (DD/II) was reported in previous studies done among Chinese, 51 German, 52, 53 Danish, 54 Turkish, 4, 55, 56 Korean, 57 Iranian 58,59 and Dutch 60 diabetic cases.
This discrepancy in polymorphisms association studies may possibly be due to several factors, including variations in ethnic background of the cases and controls, the possible criteria of inclusion and exclusion of cases and lack of statistical power due to small sample sizes. In conclusion, this work indicated that the MTHFR C677T, A1298C genetic polymorphisms may be considered as genetic risk factors for DN, particularly in the form of macroalbuminuria, whereas ACE DD genotype was an additive marker for the development of microalbuminuria among Egyptian type 2 diabetic patients. 
